(Q43287803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs--a proof of principle study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Elizabeth J. Norman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Barbara King

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

9

Robert D Jolly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

10

John J Hopwood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Allison C Crawley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Dyane Auclair

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Maria Fuller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Debbie L Lang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Caroline J Dean

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

28 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

383-392

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19699666%20AND%20SRC:MED&resulttype=core&format=json

Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Structure and sequence of the human sulphamidase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Enzyme-replacement therapy in mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and S

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Mucopolysaccharidosis IIIA (Sanfilippo syndrome) in a New Zealand Huntaway dog with ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Pathology of Mucopolysaccharidosis IIIA in Huntaway Dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Newborn screening for lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Characterization of sulfated oligosaccharides in mucopolysaccharidosis type IIIA by electrospray ionization mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

Vector delivery methods and targeting strategies for gene therapy of brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.07.013

10.1016/J.YMGME.2009.07.013

7 January 2021

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3j4vkmdlovgqjcdmsoh7ldbmiq

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_3j4vkmdlovgqjcdmsoh7ldbmiq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3j4vkmdlovgqjcdmsoh7ldbmiq

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/3j4vkmdlovgqjcdmsoh7ldbmiq

1 reference